Feline Vitamin D Toxicosis (Cholecalciferol Poisoning)

Feline Vitamin D Toxicosis, also known as cholecalciferol poisoning, is a life-threatening metabolic disorder in cats resulting from excessive intake of Vitamin D₃ (cholecalciferol) or its analogues. The condition leads to hypercalcemia and hyperphosphatemia, triggering widespread soft tissue mineralization—termed systemic calcinosis—across multiple organ systems [1]. Cats may be exposed through contaminated commercial diets, rodenticide baits containing cholecalciferol, or excessive dietary supplementation. Because cats are highly sensitive to Vitamin D excess compared to many other species, even relatively modest over-supplementation can produce severe, potentially fatal outcomes [1].

Sources of Exposure

Feline Vitamin D Toxicosis arises from excessive exogenous intake of cholecalciferol (Vitamin D₃) or related compounds. Documented sources include:

• ·Contaminated commercial cat food: Natural outbreaks have been described in which multiple cats within a colony were simultaneously affected, strongly implicating a shared dietary source as the vehicle [1].
• ·Cholecalciferol-based rodenticides: Products designed to kill rodents by inducing hypercalcemia are a significant hazard when ingested by cats.
• ·Over-supplementation: Excessive use of Vitamin D-containing nutritional supplements.

Pathophysiological Mechanism

Cholecalciferol is metabolized in the liver to 25-hydroxycholecalciferol and subsequently in the kidney to the biologically active 1,25-dihydroxycholecalciferol (calcitriol). In toxic quantities, calcitriol:

1. ·Increases intestinal calcium absorption: Dramatically upregulates calcium transport in the duodenum, elevating serum calcium.
2. ·Promotes renal calcium reabsorption and bone resorption: Further driving hypercalcemia and contributing to hyperphosphatemia.
3. ·Triggers ectopic mineralization: When the calcium × phosphorus product exceeds a critical threshold, calcium-phosphate crystals precipitate in soft tissues. Histopathological examination of naturally affected cats confirmed marked calcification of vascular walls in virtually all organs, including the lungs, trachea, kidneys, heart, aorta, and alimentary tract [1].
4. ·Causes progressive organ dysfunction: Renal tubular and glomerular calcification leads to acute kidney injury (evidenced by elevated BUN and creatinine); pulmonary calcification impairs gas exchange; cardiac calcification precipitates arrhythmias [1].
5. ·Skeletal changes: Radiography in affected cats demonstrated increased systemic bone density, reflecting the complex interplay between hypervitaminosis D, hypercalcemia, and bone metabolism [1].

The cascade from exposure to multiorgan failure can occur rapidly, particularly in cats with high-level acute exposures.

Clinical History and Physical Examination

A diagnosis of Vitamin D Toxicosis should be suspected in any cat presenting with hypercalcemia, especially when accompanied by a history of dietary change, potential rodenticide exposure, or a cluster of cases in a multi-cat household or cattery. Physical examination may reveal depression, dehydration, muscle weakness, and evidence of respiratory compromise [1].

Laboratory Findings

Hematology and serum biochemistry are central to diagnosis. Key abnormalities documented in naturally affected cats include [1]:

Notably, elevated phosphorus, BUN, and creatinine were specifically documented in the natural outbreak series [1].

Serum 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D

Measurement of circulating 25-hydroxycholecalciferol (calcidiol) confirms excess Vitamin D exposure and can help differentiate cholecalciferol toxicosis from other causes of hypercalcemia (e.g., hypercalcemia of malignancy, primary hyperparathyroidism, idiopathic hypercalcemia).

Radiographic Findings

Plain radiographs are a valuable non-invasive diagnostic tool. Increased density of systemic bones was documented in affected cats [1], and mineralization of soft tissues (vascular calcifications, pulmonary infiltrates) may also be visible. Thoracic radiographs may reveal diffuse interstitial or nodular pulmonary mineralization.

Histopathology

In deceased or euthanized cases, histopathological examination confirms the diagnosis by demonstrating marked calcification of vascular walls across almost all organ systems, including the lungs, trachea, kidneys, heart, aorta, and gastrointestinal tract [1]. This finding is pathognomonic in the appropriate clinical context.

Differential Diagnoses

• ·Hypercalcemia of malignancy (lymphoma, carcinoma)
• ·Primary hyperparathyroidism
• ·Chronic kidney disease with secondary mineral imbalance
• ·Idiopathic hypercalcemia of cats
• ·Other rodenticide toxicoses

Treatment is aimed at reducing serum calcium, halting further Vitamin D absorption, and supporting organ function. There is no specific antidote for cholecalciferol toxicosis; management is largely symptomatic and supportive.

Decontamination (Acute Ingestion)

• ·Emesis induction: If ingestion is very recent (within 1–2 hours) and the cat is alert, induction of emesis may be appropriate. Note that emesis induction in cats carries risks and should be performed only under veterinary supervision.
• ·Activated charcoal: May reduce ongoing intestinal absorption of cholecalciferol; however, evidence for efficacy in cats is limited and must be weighed against risks (particularly hypernatremia with repeated dosing).

Intravenous Fluid Therapy

• ·0.9% NaCl (normal saline) is the fluid of choice as it promotes calciuresis (renal calcium excretion) by providing volume expansion and sodium loading. Aggressive IV fluid diuresis is a cornerstone of treatment.

Pharmacological Calcium Reduction

• ·Furosemide (loop diuretic): Promotes renal calcium excretion in conjunction with saline diuresis; requires careful monitoring of electrolytes and hydration status.
• ·Glucocorticoids (prednisolone/dexamethasone): Reduce intestinal calcium absorption, decrease bone resorption, and increase renal calcium excretion. They are particularly useful in Vitamin D toxicosis as they directly antagonize Vitamin D's effects on intestinal transport.
• ·Bisphosphonates (e.g., pamidronate): Inhibit osteoclast-mediated bone resorption and reduce calcium release from bone; increasingly used in refractory hypercalcemia cases in small animals.
• ·Calcitonin: Can transiently reduce serum calcium by inhibiting bone resorption and promoting renal calcium excretion; may be used as adjunctive therapy.

Dietary Management

• ·Strict elimination of all Vitamin D-containing supplements or the suspected contaminated diet is mandatory.
• ·Low-calcium diet: Should be implemented during and after treatment to minimize ongoing calcium loading.

Renal Support

Given that azotemia (elevated BUN and CREA) is a documented feature of this toxicosis [1], renal supportive care—including IV fluids, monitoring of urine output, and management of electrolyte imbalances—is essential. Cats with severe nephrotoxicity may require referral for dialysis.

Monitoring During Treatment

Serial monitoring of serum calcium, phosphorus, BUN, creatinine, and electrolytes is critical. Due to the long half-life of cholecalciferol and its metabolites, treatment may need to be sustained for weeks, as toxicosis can recur or persist long after the exposure has been removed.

The prognosis for feline Vitamin D Toxicosis is guarded to poor, particularly in cases with established multiorgan calcinosis. In the natural outbreak described by Morita et al. (1995), 21 cats were affected, and pathological examination was performed on 5 cats, implying significant mortality within the affected population [1]. The documentation of severe, widespread vascular and parenchymal calcification—including renal, pulmonary, cardiac, and gastrointestinal involvement—in these 5 cats underscores the life-threatening nature of advanced disease [1].

Key prognostic factors include:

• ·Severity and duration of hypercalcemia: Prolonged or profound hypercalcemia correlates with more extensive irreversible mineralization.
• ·Degree of renal involvement: Cats presenting with significant azotemia (elevated BUN and CREA) have a worse prognosis, as nephrocalcinosis may progress to irreversible chronic kidney disease even if the primary insult is addressed [1].
• ·Extent of cardiac and pulmonary calcification: Mineralization of the heart and lungs can cause fatal arrhythmias or respiratory failure.
• ·Speed of diagnosis and treatment: Early decontamination and intervention before extensive mineralization occurs substantially improves outcomes.

Because cholecalciferol and its active metabolites have long biological half-lives, cats that survive the acute phase require prolonged management and monitoring, and some may develop permanent renal impairment. The condition carries meaningful mortality, particularly when diagnosis and treatment are delayed.

Dietary Vigilance

• ·Verify nutritional adequacy of commercial diets: Pet owners and veterinarians should be aware of recalls or manufacturer notifications related to Vitamin D over-supplementation in commercial cat foods. The natural outbreak documented in the literature [1] highlights that contaminated commercial diets can affect multiple cats simultaneously.
• ·Avoid unsupervised supplementation: Vitamin D supplements should never be administered to cats without explicit veterinary guidance and dosage verification.
• ·Balance homemade diets carefully: Cats fed homemade or raw diets should have their nutritional formulation reviewed by a board-certified veterinary nutritionist to ensure Vitamin D levels fall within safe ranges.

Toxin Avoidance

• ·Secure storage of cholecalciferol-based rodenticides: These products must be stored out of reach of cats and used with appropriate precautions. Pet-safe rodent control alternatives should be considered in households with cats.
• ·Caution with vitamin-mineral supplements: Multi-vitamin products formulated for humans or other species should never be used in cats, as Vitamin D requirements and tolerances differ significantly between species.

Monitoring in Multi-Cat Environments

• ·When multiple cats share a diet, any cluster of similar clinical signs (lethargy, vomiting, PU/PD) warrants immediate veterinary evaluation and dietary analysis, as a shared dietary source can cause outbreak-level toxicosis [1].

Routine Veterinary Surveillance

• ·Annual or biannual wellness bloodwork can help detect early hypercalcemia or hyperphosphatemia before clinical signs are apparent, enabling earlier intervention in subclinical cases.